Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide in Rheumatoid Arthritis
NCT06640309Phase 2Recruiting
- Sponsor
- Ain Shams University
- Start
- Dec 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide in rheumatoid arthritis (RA), sponsored by Ain Shams University. Started Dec 2023; status: recruiting.
02
Drugs
nicotinamide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06640309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06640309.